According to previous research, SEZ6L2 has been shown to be regulated by transcription factors, such as STAT3, which upregulate the expression of the vascular endothelial growth factor and promote tumor angiogenesis and cancer progression [20, 21]. This evidence concerns the gene VEGFA and neoplasm.